Alicia Senín

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition

Miquel Granell, Xavier Calvo, Antoni García‐Guiñón et al. · Haematologica · 2017 · 128 citations · Full text

Medicine, Hematology, Oncology +12

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

Sundar Jagannath, Yi Lin, Hartmut Goldschmidt et al. · Blood Cancer Journal · 2021 · 87 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea

Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, Juan Carlos Hernández‐Boluda et al. · Annals of Hematology · 2014 · 78 citations

Medicine, Hematology, Pharmacology +6

<scp>WHO</scp>‐histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes

Alberto Álvarez‐Larrán, Águeda Ancochea, M. García García et al. · British Journal of Haematology · 2014 · 68 citations

Medicine, Hematology, Pathology +16

<i>JAK2</i>V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

Alberto Álvarez‐Larrán, Beatríz Bellosillo, Arturo Pereira et al. · American Journal of Hematology · 2014 · 53 citations · Full text

Medicine, Hematology, Pathology +10